Time of progression to type 2 diabetes study period [clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887]

Time of progression to type 2 diabetes study period [clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887]

oral administration once daily
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887
Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes (RAPSODI) [clinicaltrials:NCT00325650]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Time of progression to type 2 diabetes study period [clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887]

oral administration once daily
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887
Bio2RDF identifier
0324c123370bab1b38fb3cef7c939887
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887
measure [clinicaltrials_vocabulary:measure]
Time of progression to type 2 diabetes
time frame [clinicaltrials_vocabulary:time-frame]
description
oral administration once daily
identifier
clinicaltrials_resource:0324c123370bab1b38fb3cef7c939887
title
Time of progression to type 2 diabetes study period
@en
inDataset
type
label
Time of progression to type 2 ...... 4c123370bab1b38fb3cef7c939887]
@en